Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIGLUSTAT vs ELTROMBOPAG OLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIGLUSTAT vs ELTROMBOPAG OLAMINE: Safety Overview

Metric ELIGLUSTAT ELTROMBOPAG OLAMINE
Total FAERS Reports 1,368 16,074
Deaths Reported 18 3,457
Death Rate 1.3% 21.5%
Hospitalizations 173 3,284
Average Patient Age 48.6 yrs 56.5 yrs
% Female Patients 57.1% 57.7%
FDA Approval Date Aug 17, 2022 Apr 18, 2024
Manufacturer Genzyme Corporation XLCare Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription